Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience.
Di Pietro FR, Marinelli D, Verkhovskaia S, Poti G, Falcone R, Carbone ML, Morelli MF, Zappalà AR, Di Rocco ZC, Morese R, Piesco G, Chesi P, Marchetti P, Failla CM, De Galitiis F. Di Pietro FR, et al. Among authors: morese r. BMC Cancer. 2024 Oct 1;24(1):1220. doi: 10.1186/s12885-024-12961-9. BMC Cancer. 2024. PMID: 39354418 Free PMC article.
Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients.
Verkhovskaia S, Di Pietro FR, Mastroeni S, Carbone ML, Abeni D, Morese R, Morelli FM, D'Atri S, Marchetti P, De Galitiis F, Failla CM, Fortes C. Verkhovskaia S, et al. Among authors: morese r. J Cancer Res Clin Oncol. 2022 Sep;148(9):2529-2538. doi: 10.1007/s00432-021-03811-3. Epub 2021 Sep 30. J Cancer Res Clin Oncol. 2022. PMID: 34595541
Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center.
Falcone R, Verkhovskaia S, Di Pietro FR, Poti G, Samela T, Carbone ML, Morelli MF, Zappalà AR, di Rocco ZC, Morese R, Piesco G, Marchetti P, Failla CM, De Galitiis F. Falcone R, et al. Among authors: morese r. Curr Oncol. 2024 Jan 22;31(1):588-597. doi: 10.3390/curroncol31010042. Curr Oncol. 2024. PMID: 38275835 Free PMC article.
Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients.
Di Pietro FR, Verkhovskaia S, Falcone R, Poti G, Carbone ML, Morelli MF, Zappalà AR, Morese R, Di Rocco ZC, Piesco G, Chesi P, Failla CM, Marchetti P, De Galitiis F. Di Pietro FR, et al. Among authors: morese r. Front Oncol. 2024 Aug 1;14:1437325. doi: 10.3389/fonc.2024.1437325. eCollection 2024. Front Oncol. 2024. PMID: 39148899 Free PMC article.
Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding study.
Ficorella C, Ricevuto E, Morelli MF, Morese R, Cannita K, Cianci G, Porzio G, Di Rocco ZC, De Galitiis F, De Tursi M, Tinari N, Iacobelli S, Marchetti P. Ficorella C, et al. Among authors: morese r. Oncol Rep. 2006 May;15(5):1345-50. doi: 10.3892/or.15.5.1345. Oncol Rep. 2006. PMID: 16596209 Clinical Trial.
Treatment-related side effects and quality of life in cancer patients.
Mazzotti E, Antonini Cappellini GC, Buconovo S, Morese R, Scoppola A, Sebastiani C, Marchetti P. Mazzotti E, et al. Among authors: morese r. Support Care Cancer. 2012 Oct;20(10):2553-7. doi: 10.1007/s00520-011-1354-y. Epub 2012 Jan 21. Support Care Cancer. 2012. PMID: 22270087
[The integrated care pathway for non melanoma skin cancer: the Istituto Dermopatico dell'Immacolata - IRCCS experience in Rome.].
Fania L, Morese R, Di Lella G, Palese E, Mazzanti C, Pallotta S, Panebianco A, Laporta R, Caggiati A, Passarelli F, Ziparo V, Tartaglione T, Candi E, Dellambra E, Di Pietro FR, De Galitiis F, Marchetti P, Abeni D. Fania L, et al. Among authors: morese r. Recenti Prog Med. 2020 Dec;111(12):749-760. doi: 10.1701/3509.34966. Recenti Prog Med. 2020. PMID: 33362172 Italian.
64 results